retatrutide approval - Find Top Weight Loss Doctors Near You RETATRUTIDE (RETA)

Obesity 17 , 16711677 (2009)

nih Jastreboff A.M., Kaplan L.M., Fras J.P., Wu Q., Du Y., Gurbuz S., Coskun T., Haupt A., Milicevic Z., Hartman M.L

These participants were randomized to once-weekly subcutaneous retatrutide (1, 4, 8, or 12 mg) or placebo for 48 weeks

One is FDA-approved and available right now

The first could be simply due to the time of testing relative to the last injection being different from the last test

If you have medullary thyroid cancer or genetic testing that puts you at risk for thyroid cancer, or you have a family member who has medullary thyroid cancer, they say you shouldn't use these drugs